SELLAS Life Sciences Group, Inc. (SLS) Gross margin 2020–2022
SELLAS Life Sciences Group, Inc. (SLS) gross margin by fiscal year — reported gross profit divided by reported revenue.
90.0%FY2022 · since FY2020: 100.0% → 90.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 90.0% | -7.4 pp |
| FY2021 | 97.4% | -2.6 pp |
| FY2020 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice